Navigating Ethical Considerations When Supporting Scale Up of Health Interventions

Description

Moderator Dr. Ben Cislaghi provided an initial framing on ethical principles and values using four metaphors for framing global health: as a supermarket, a boxing ring, a colony, and/or a juggernaut. Like supermarkets, global health is often focused on selling outputs, such as vaccines. Global health is like a boxing ring because when a product gets on the market it becomes a fight over who can do it the cheapest and the fastest. Global health is a colony because most people working on global health are either coming from or are educated in the global north and may not share the values or priorities of the global south. Global health is a juggernaut because it moves quickly from one intervention to the next with little time to pause and reflect. The speed is dehumanizing and lacks compassion.

Ben introduced the panelists and posed a question to Dr. Chole Schwenke on how to engage and find solutions to navigate the different values of diverse stakeholders when scaling health interventions. Chloe conceded that development practitioners are not very good at finding shared values because there isn’t a lot of focus on ethics and values beyond concepts like “do no harm.” The starting point should be values mapping to identify places of value alignment and find out where the conflicts are likely to be. As we scale up it’s best to move to an inclusive development assessment process with formal qualitative research that leverages active listening. The starting point should be a shared commitment to respect equal, universal human dignity.

Ben asked Louise Agersnap what ethical questions are imperative to consider in the design of scaling interventions. Louise said the first questions to ask are always: why are we scaling this, and for whom are we scaling it? Innovations are often supply driven and shaped by commercial market focus rather than being for and by the people they serve.  That’s far from ideal. Sustainability is also a matter of ethics, so the WHO Innovation Hub is taking a primary healthcare approach to scaling interventions to ensure sustainability and empower communities.

The discussion then moved to a question on how to ensure equitable access to digital health technology, particularly for marginalized communities. Diogo Mochcovitch echoed the importance of thinking about who a digital health technology is designed for and barriers that exist. Users must be able to understand how to use smartphones, how to use the apps, and understand the digital information. Expand infrastructure to ensure internet access for all. Provide smartphones to people who don’t have them (possibly using donated or refurbished devices in partnership with companies) to improve equity. Chloe brought up that it’s critical to address the issues of patriarchy, since so much related to women’s access is controlled by men. Developers must deal with structural issues and reflect on values and norms that need to change.

Chloe also raised the problem posed by the data desert in low- and middle-income countries. Data for AI is based on the global north—what does that mean for the global south? It’s going to take resources and a recognition that the global north can’t just harvest data; it needs to be owned by the people whose data it is. Who owns the data and gets to interpret what it means?

Ben invited Louise to expand on what ethical principles should frame health intervention scaling strategies. Louise said WHO/EN guidance – Nine Steps for developing a scaling up strategy – provides an ethics infused and practical approach to maintain respect for human rights, equity, gender perspectives, and client centered approaches. She finds systems approaches very important in terms of understanding the larger environment where scaling takes place, and how changing one element impacts the others. It’s also important to focus on sustainability, paying attention to institutionalizing the innovation and to the wider context that will allow an innovation to take root and survive. Root the scale-up strategy on a respect for human rights and gender perspectives. Some innovations increase gender equity, but others may have a negative impact.

Dr. Peter Waisa emphasized that understanding the context in which scale up will happen is important, as well as co-creation, having champions, and being flexible. Think about culture and place and ensure you are respectful. There is no one size fits all approach. Tailor messaging to the community and their needs and values. Co-creation and human-centered design are critical to avoid failure. Include cultural leaders and elders in the conversation but consider the priorities of youth as well. Implementers need to understand that people have rights and need to consent. Many health interventions do not have impact because evidence does not interact with local context. It’s not effective to just import from the capital to the countryside. It’s important to co-create and recognize local expertise. It’s also important to take local feedback during implementation.

In closing, the discussion turned back to AI and what issues it poses for ethics and human rights. Chloe brought up the field of machine ethics. AI doesn’t think – data scientists write the algorithms, and many ethical frameworks exist that can help AI to behave ethically. AI will pick up the biases in the data unless we filter those biases out. However, there’s much more work to do to elevate core values and build them into AI. Diogo brought up privacy protection risks, which can be mitigated with data transparency and new governance models for how AI can work. Infotech companies have a great responsibility and require regulation, but it’s important to expand to people beyond data scientists in developing the code. Researchers can serve as the bridge between the big actors. NGOs can be partners. Impacted people are the most important to consider, so include them from the beginning.

event_description_image_169484_1709814847_55ea6.png?_a=BAAASyDQ
Dr. Chloe Schwenke: President and Founder – The Center for Values in International Development

Dr. Chloe Schwenke is a development ethicist, researcher, academic, and international development practitioner. She currently serves as the president and founder of the non-profit Center for Values in International Development. Chloe is an experienced leader and manager of non-profit organizations, having served previously in the Washington DC region as vice president of Freedom House, as research director at the International Center for Research on Women, and at USAID as Senior Advisor on Democracy, Rights and Governance in Africa, as a political appointee in the Obama administration. She has technical expertise in applied ethics & human rights, ethics of Artificial Intelligence, LGBTQI+ concerns, gender equality and social inclusion, transformational leadership, and public policy. She has both North American and international work experience in 42 countries, and has lived and worked in East and South Asia, the Middle East (including the Gaza Strip and West Bank), Eastern Europe, and Africa for more than 15 years, with very recent work experience in Bangladesh and India. Chloe is also an accomplished writer, public speaker, and trainer.

Chloe earned her doctorate in public policy from the School of Public Policy at the University of Maryland, and her master’s degree from Georgetown University. She is on the adjunct faculty of the McCourt School of Public Policy at Georgetown University, and at the School of Public Policy at the University of Maryland.

event_description_image_169484_1709814959_0097e.png?_a=BAAASyDQ
Dr. Diogo Mochcovitch: Research Coordinator, VITAM – Center for Research in Sustainable Health, Integrated University Center of Health and Social Services – Laval University

Diogo Mochcovitch holds a PhD in Philosophy, complemented by two postdoctoral fellowships—one in Bioethics, Applied Ethics, and Public Health, and another in Medicine. Currently, he serves as a research coordinator at the Canada Chair of Shared Decision-Making and Knowledge Mobilization. Within this role, he analyzes the ethical implications of scaling across diverse contexts, grounded in philosophical principles. Mochcovitch’s focus extends to promoting equity and social justice in scaling, contributing to the enhancement of ethical practices within scaling science.

 

event_description_image_169484_1709815220_b812d.png?_a=BAAASyDQ
Dr. Peter Waiswa: Associate Professor, School of Public Health – Makarere University

Dr. Waiswa is an Associate Professor of Health Policy Planning and Management of the School of Public Health at Makerere University College of Health Sciences. His focus areas are mainly health systems, implementation research, and policy influence in reproductive health, maternal, newborn and child health. He is a leading African academic with over 200 peer-reviewed publications. Dr. Waiswa is actively involved in local, national, and global policy-making and implementation. He is also a member of the WHO Strategic and Technical Advisory Group of Experts (STAGE) for Maternal, Newborn, Child and Adolescent Health and Nutrition, which provides independent advice to the WHO Director General. He is also a member of the Lancet Commission on Evidence-based implementation.

event_description_image_169484_1709815398_0b940.png?_a=BAAASyDQ
Louise Agersnap: Head – WHO Innovation Hub

Louise Agersnap (MA and B.A. Pol. Sci.; B.H.A.) is a Political Scientist and innovation and change leader with extensive experience & knowledge of global affairs in health, development, and the innovation ecosystem, acquired through 20+ years in the United Nations, private sector & government, NGO, and academia. Currently leading the Innovation Hub at the World Health Organization, at times acting Director for the Department for Digital Health and Innovation, Mrs Agersnap leads the strategy shaping and execution of WHO’s innovation in health mission and promotes the Global Strategy for Digital Health. She spearheads the scaling of Primary Health Care innovations to address neglected problems in low- resource settings, e.g. chronic diseases, mental health, newborn and maternal health, and the strengthening of organizational culture for creativity and inclusive collaboration. Throughout, she draws on her political science background and experience in applying a systems innovation lens, social and technological innovations, and design thinking to transform societal health and development. In previous roles, Louise led WHO’s global culture and values work, facilitated private sector engagement on chronic diseases, and promoted UN reform efforts from New York and Panama. A selling artist in her spare time, her works have featured at the International Contemporary Art Fair in Luxembourg, and the Van Gogh Art Gallery in Madrid, Spain.

event_description_image_169484_1709815561_3c90f.png?_a=BAAASyDQ
Dr. Mojisola Odeku: Senior Program Officer, Family Planning, Maternal, Newborn and Child Health/Primary Health Care, Program Advocacy and Communication – Bill and Melinda Gates Foundation

Dr. Mojisola Odeku has been a longtime leader in the reproductive health landscape in Nigeria, and a veteran public health physician with 30+ years of experience. In her roles in the Federal Ministry of Health as the former Head of the Reproductive Health Program, Dr. Odeku focused on safe motherhood, family planning, including contraceptive logistic management, adolescent reproductive health and gender issues. She has experience with the development of strategic plans, policy guidelines, advocacy, research and contraceptive logistic management systems for reproductive health programs. Dr. Odeku was Project Director of Phases I and II of the Nigeria Urban Reproductive Health Initiative (NURHI – 2009-2020) with the Johns Hopkins University Center for Communications Programs, which had the vision of scaling up proven family planning and reproductive health interventions. She has provided strategic direction as coordinator of the Government of Nigerian intervention projects in reproductive/maternal health with support from international foundations (MacArthur and Packard), multilateral agencies (UNFPA, UNICEF, World Bank and WHO) and bilateral agencies (USAID and JICA). Dr. Odeku also serves on the executive board of notable national and international NGOs working in reproductive and population programs such as International Council on Management of Population programs (ICOMP) and Advocacy Nigeria.

event_description_image_169484_1709816011_e0272.png?_a=BAAASyDQ
MODERATOR: Dr. Ben Cislaghi – Humanising Development Collective

Ben is a courageous thinker and doer who brings innovation across sectors and disciplines. He has collaborated with several NGOs (Oxfam, Tostan, Save, Care, Plan), UN organizations (UNICEF, ILO, WHO), and Universities (including Stanford, Columbia, LSHTM, Hopkins, Makerere) where he was globally recognised for his work on gender equality and social justice. These past professional experiences have fuelled his interest to find new compassionate imaginative alternatives for mutual global collaboration, envisioning with others mutually beneficial ways of collaborating.